Unraveling the Klinefelter's Disease Physiopathology
Launched by CLINIQUES UNIVERSITAIRES SAINT-LUC- UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Aug 11, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding Klinefelter Syndrome (KS), a genetic condition in males caused by an extra X chromosome. This condition is often linked to infertility, particularly the inability to produce sperm, known as azoospermia. Researchers will take special cells from the testes of KS patients and use a lab technique called an organoid model to study how these cells behave when mixed with different types of supporting cells. The goal is to find out how these interactions might affect fertility in men with KS.
The trial is currently looking for male participants aged 18 to 26 who have been diagnosed with Klinefelter Syndrome. Unfortunately, men with a specific variation of Klinefelter Syndrome known as mosaicism cannot participate. If you join the study, you will help researchers gain insights that could lead to better treatments for infertility related to Klinefelter Syndrome. This is an important step in understanding how to support men with this condition in their journey towards fatherhood.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Klinefelter
- Exclusion Criteria:
- • Mosaicism
About Cliniques Universitaires Saint Luc Université Catholique De Louvain
Cliniques Universitaires Saint-Luc, affiliated with the Université Catholique de Louvain, is a leading academic medical center in Belgium dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, it focuses on a wide range of therapeutic areas, prioritizing patient safety and ethical standards. The institution is committed to fostering collaboration between researchers and clinicians to enhance medical knowledge and improve treatment outcomes, contributing significantly to the global scientific community and the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Patients applied
Trial Officials
Christine Wyns, MD, PhD
Principal Investigator
Cliniques Universitaires St Luc
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported